Linked Life Data

12036941

Source:http://linkedlifedata.com/resource/pubmed/id/12036941

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12036941rdf:typepubmed:Citationlld:pubmed
pubmed-article:12036941lifeskim:mentionsumls-concept:C0005684lld:lifeskim
pubmed-article:12036941lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:12036941lifeskim:mentionsumls-concept:C0525039lld:lifeskim
pubmed-article:12036941lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:12036941lifeskim:mentionsumls-concept:C0205214lld:lifeskim
pubmed-article:12036941pubmed:issue11lld:pubmed
pubmed-article:12036941pubmed:dateCreated2002-5-30lld:pubmed
pubmed-article:12036941pubmed:abstractTextDNA polymerase beta (POLbeta) is a highly conserved protein that functions in base excision repair. Loss of the POLbeta locus on chromosome 8p is a frequent event in bladder cancer, and loss of POLbeta function could hinder DNA repair leading to a mutator phenotype. Both point mutations and large intragenic deletions of POLbeta have been reported from analysis of various tumor cDNAs but not from genomic DNA. We noticed that the breakpoints of the presumed rearrangements were delineated by exon-exon junctions, which could instead be consistent with alternative splicing of POLbeta mRNA. We tested the hypothesis that the reported intragenic deletion were splice variants by screening genomic DNA of human bladder tumors, bladder cancer cell lines, and normal bladder tissues for mutations or deletions in exons 1-14, exon alpha, and the promoter region of POLbeta. We found no evidence of somatic mutations or deletions in our sample set, although two polymorphisms were identified. Examination of cDNA from a subset of the original sample set revealed that truncated forms of POLbeta were surprisingly common. Forty-eight of 89 (54%) sequenced cDNA clones had large deletions, each beginning and/or ending exactly at exon-exon junctions. Because these deletions occur at exon-exon junctions and are seen in cDNA but not genomic DNA, they are consistent with alternative mRNA splicing. We describe 12 different splicing events occurring in 18 different combinations. Loss of exon 2 was the most frequent, being found in 42 of 49 (86%) of the variant sequenced clones. The splice variants appear to be somewhat more common and variable in bladder cancer cell lines and tumor tissues but occur at a high frequency in normal bladder tissues as well. We examine alternative splicing in terms of the information content of splice donor and acceptor site sequences, and discuss possible explanations for the predominant splicing event, the loss of exon 2.lld:pubmed
pubmed-article:12036941pubmed:languageenglld:pubmed
pubmed-article:12036941pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12036941pubmed:citationSubsetIMlld:pubmed
pubmed-article:12036941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12036941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12036941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12036941pubmed:statusMEDLINElld:pubmed
pubmed-article:12036941pubmed:monthJunlld:pubmed
pubmed-article:12036941pubmed:issn0008-5472lld:pubmed
pubmed-article:12036941pubmed:authorpubmed-author:TaylorJack...lld:pubmed
pubmed-article:12036941pubmed:authorpubmed-author:ThompsonTracy...lld:pubmed
pubmed-article:12036941pubmed:authorpubmed-author:RoganPeter...lld:pubmed
pubmed-article:12036941pubmed:authorpubmed-author:RisingerJohn...lld:pubmed
pubmed-article:12036941pubmed:issnTypePrintlld:pubmed
pubmed-article:12036941pubmed:day1lld:pubmed
pubmed-article:12036941pubmed:volume62lld:pubmed
pubmed-article:12036941pubmed:ownerNLMlld:pubmed
pubmed-article:12036941pubmed:authorsCompleteYlld:pubmed
pubmed-article:12036941pubmed:pagination3251-6lld:pubmed
pubmed-article:12036941pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:meshHeadingpubmed-meshheading:12036941...lld:pubmed
pubmed-article:12036941pubmed:year2002lld:pubmed
pubmed-article:12036941pubmed:articleTitleSplice variants but not mutations of DNA polymerase beta are common in bladder cancer.lld:pubmed
pubmed-article:12036941pubmed:affiliationMolecular and Genetic Epidemiology Group, The Laboratory of Molecular Carcinogenesis, The National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.lld:pubmed
pubmed-article:12036941pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12036941pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12036941lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12036941lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12036941lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12036941lld:pubmed